Ira Braunschweig

12.0k total citations
76 papers, 2.0k citations indexed

About

Ira Braunschweig is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Ira Braunschweig has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 36 papers in Oncology and 24 papers in Immunology. Recurrent topics in Ira Braunschweig's work include CAR-T cell therapy research (23 papers), Acute Myeloid Leukemia Research (18 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Ira Braunschweig is often cited by papers focused on CAR-T cell therapy research (23 papers), Acute Myeloid Leukemia Research (18 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Ira Braunschweig collaborates with scholars based in United States, France and Canada. Ira Braunschweig's co-authors include Donna Przepiorka, Sergio Giralt, Paolo Anderlini, Richard E. Champlin, Issa F. Khouri, Naoto T. Ueno, David F. Claxton, James Gajewski, Börje S. Andersson and Michael Andreeff and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Ira Braunschweig

68 papers receiving 1.9k citations

Peers

Countries citing papers authored by Ira Braunschweig

Since Specialization

Citations

This map shows the geographic impact of Ira Braunschweig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira Braunschweig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira Braunschweig more than expected).

Fields of papers citing papers by Ira Braunschweig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ira Braunschweig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira Braunschweig. The network helps show where Ira Braunschweig may publish in the future.

Co-authorship network of co-authors of Ira Braunschweig

This figure shows the co-authorship network connecting the top 25 collaborators of Ira Braunschweig. A scholar is included among the top collaborators of Ira Braunschweig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ira Braunschweig. Ira Braunschweig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma 2024 ·Transplantation and Cellular Therapy ·Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett, Lazaros J. Lekakis, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi, Yi Lin, John M. Timmerman, Marie José Kersten, (unknown), (unknown), (unknown), Rhine R. Shen, Harry Miao, Jenny Kim, David B. Miklos	13
2	Efficacy and safety of ciltacabtagene autoleucel ± lenalidomide maintenance in newly diagnosed multiple myeloma with suboptimal response to frontline autologous stem cell transplant: CARTITUDE-2 cohort D. 2024 ·Journal of Clinical Oncology ·Bertrand Arnulf, Tessa Kerre, Mounzer Agha, Michel Delforge, Ira Braunschweig, Nishi Shah, Shambavi Richard, Melissa Alsina, Hermann Einsele, Pankaj Mistry, Helen Varsos, (unknown), Jordan M. Schecter, Kevin C. De Braganca, Yogesh Jethava, Qingxuan Song, Mythili Koneru, Muhammad Akram, Yaël C. Cohen, Wilfried Roeloffzen	2
3	A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML 2023 ·Clinical Cancer Research ·David Levitz, Yogen Saunthararajah, (unknown), Lauren Shapiro, Ioannis Mantzaris, Aditi Shastri, Noah Kornblum, R. Alejandro Sica, Nishi Shah, Marina Konopleva, Kira Gritsman, Ira Braunschweig, Dennis Cooper, Kith Pradhan, Amit Verma, Eric J. Feldman, Mendel Goldfinger	10
4	Global Longitudinal Strain Is Associated with Mortality in Patients with Multiple Myeloma 2023 ·Journal of Clinical Medicine ·(unknown), Francesco Castagna, (unknown), (unknown), Lili Zhang, James M. Tauras, Ira Braunschweig, Gurbakhash Kaur, Murali Janakiram, Yanhua Wang, Yanan Fang, Juan Carlos Díaz, Carolina Hoyos, (unknown), Patricia A. Pellikka, Jorge Romero, Mario J. García, Amit Verma, Nishi Shah, Leandro Slipczuk	1
5	High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events 2023 ·PubMed ·Timothy M. E. Davis, (unknown), (unknown), Lauren Shapiro, Aditi Shastri, Kira Gritsman, Nishi Shah, R. Alejandro Sica, Marina Konopleva, Eric J. Feldman, Ioannis Mantzaris, Ira Braunschweig, Amit Verma, Dennis Cooper, Noah Kornblum, Mendel Goldfinger	0
6	AML-351 Low-Dose Weekly Decitabine and Venetoclax in Myeloid Malignancies 2022 ·Clinical Lymphoma Myeloma & Leukemia ·Lauren M. Shapiro, Ioannis Mantzaris, Aditi Shastri, Alejandro Sica, Nishi Shah, Noah Kornblum, Kira Gritsman, Eric J. Feldman, Amit Verma, Ira Braunschweig, Yogen Saunthararajah, Mendel Goldfinger	0
7	Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma 2021 ·Blood Advances ·Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, Patrick M. Reagan, David B. Miklos, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi, Yi Lin, Michael Crump, John Kuruvilla, Eric Van Den Neste, Umar Farooq, Lynn Navale, Venita DePuy, Jaeyeon Kim, Christian Gisselbrecht	45
8	Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML 2021 ·Experimental Hematology and Oncology ·(unknown), (unknown), Nishi Shah, Jiahao Chen, Karen Fehn, Yanhua Wang, Ioannis Mantzaris, Noah Kornblum, Alejandro Sica, (unknown), Mendel Goldfinger, Kira Gritsman, Ira Braunschweig, Ulrich Steidl, Aditi Shastri, Amit Verma	9
9	Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1–Associated Adult T Cell Lymphoma–Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center 2019 ·Biology of Blood and Marrow Transplantation ·Diego Adrianzen Herrera, Noah Kornblum, Ana Acuña-Villaorduña, R. Alejandro Sica, Urvi A. Shah, (unknown), (unknown), Nishi Shah, Lizamarie Bachier‐Rodriguez, Olga Derman, Aditi Shastri, Ioannis Mantzaris, Amit Verma, Ira Braunschweig, Murali Janakiram	6
10	Ibrutinib‐induced severe liver injury 2017 ·Clinical Case Reports ·(unknown), Olga Derman, (unknown), Qiang Liu, Hatef Massoumi, Sangeetha Venugopal, Ira Braunschweig, Murali Janakiram	10
11	Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Stefan K. Barta, Rishi Jain, (unknown), Jason Carter, (unknown), Roy Browne, (unknown), (unknown), David Kaminetzky, Ramakrishna Battini, Olga Derman, Noah Kornblum, Amit Verma, Ira Braunschweig	5
12	ZUMA-1: A phase 2 multi-center study evaluating anti-CD19 chimeric antigen receptor (CAR) T cells in patients with refractory aggressive non-Hodgkin lymphoma (NHL) 2016 ·Annals of Oncology ·Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Tanya Siddiqi, Ira Braunschweig, Lazaros J. Lekakis, André Goy, Januario E. Castro, Olalekan O. Oluwole, David B. Miklos, John M. Timmerman, Caron A. Jacobson, Patrick M. Reagan, Ian W. Flinn, Umar Farooq, Patrick J. Stiff, Lynn Navale, Meg Elias, Jeff Wiezorek, William Y. Go	2
13	JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association? 2016 ·Biomarker Research ·(unknown), Amit Verma, Olga Derman, Noah Kornblum, Murali Janakiram, Ira Braunschweig, Ramakrishna Battini	2
14	Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone 2014 ·Leukemia & lymphoma ·Roni Tamari, Carolina Schinke, Tushar D. Bhagat, Michael Roth, Ira Braunschweig, Britta Will, Ulrich Steidl, Amit Verma	6
15	Eosinophilic Variant of Chronic Myeloid Leukemia with Vascular Complications 2003 ·Leukemia & lymphoma ·(unknown), (unknown), (unknown), Amy Chadburn, (unknown), Ira Braunschweig	9
16	Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia 2001 ·American Journal of Hematology ·(unknown), (unknown), Luis Fayad, Paolo Anderlini, Naoto T. Ueno, Rakesh Mehra, Issa F. Khouri, Sergio Giralt, James Gajewski, Michelle Donato, David F. Claxton, Ira Braunschweig, Koen van Besien, Michael Andreeff, Börje S. Andersson, Elihu H. Estey, Richard E. Champlin, Donna Przepiorka	19
17	Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1 2000 ·Biology of Blood and Marrow Transplantation ·(unknown), Rima M. Saliba, Karen R. Cleary, Harald E. Fischer, (unknown), Herbert A. Fritsche, Issa F. Khouri, Jody Folloder, Naoto T. Ueno, Rakesh Mehra, Cindy Ippoliti, Sergio Giralt, James Gajewski, Michèle L. Donato, David F. Claxton, Ira Braunschweig, Koen van Besien, Paolo Anderlini, Börje S. Andersson, R. Champlin	17
18	Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma 1999 ·Annals of Oncology ·Donna Przepiorka, Koen van Besien, (unknown), (unknown), Brian L. Samuels, Jody Folloder, Naoto T. Ueno, Jeffrey J. Molldrem, Rakesh Mehra, M Körbling, Sergio Giralt, J. Gajewski, Michelle Donato, Kirstie L.S. Cleary, David F. Claxton, Ira Braunschweig, B Andersson, Paolo Anderlini, Richard E. Champlin	38
19	Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation 1999 ·Bone Marrow Transplantation ·Donna Przepiorka, I. Khouri, Cindy Ippoliti, Naoto T. Ueno, Rakesh Mehra, M Körbling, Sergio Giralt, James Gajewski, Harald E. Fischer, Michèle L. Donato, Karen R. Cleary, David F. Claxton, (unknown), Ira Braunschweig, Koen van Besien, BS Andersson, Paolo Anderlini, R. Champlin	58
20	Case report 751 1992 ·Skeletal Radiology ·Ira Braunschweig, (unknown), (unknown), (unknown), (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact